Financials Cleopatra Hospitals Group S.A.E.

Equities

CLHO

EGS729J1C018

Healthcare Facilities & Services

End-of-day quote Egyptian Exchange 03:30:00 26/06/2024 am IST 5-day change 1st Jan Change
7.4 EGP +6.02% Intraday chart for Cleopatra Hospitals Group S.A.E. +7.71% +56.78%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 9,648 7,616 7,784 7,685 6,822 10,696 - -
Enterprise Value (EV) 1 8,865 7,076 7,210 7,865 7,338 12,414 12,291 11,200
P/E ratio 43.1 x 31.7 x 20.3 x 26.1 x 21.5 x 17.3 x 16.5 x 11.8 x
Yield - - - - - - - -
Capitalization / Revenue 5.37 x 3.83 x 3.05 x 2.94 x 1.9 x 2.13 x 1.92 x 1.69 x
EV / Revenue 4.93 x 3.56 x 2.83 x 3.01 x 2.04 x 2.47 x 2.21 x 1.77 x
EV / EBITDA 25.6 x 13.1 x 9.45 x 11.1 x 8.84 x 10.7 x 8.52 x 6.5 x
EV / FCF 121 x -30 x 19.7 x - - -78.1 x 150 x 21.4 x
FCF Yield 0.83% -3.33% 5.08% - - -1.28% 0.66% 4.67%
Price to Book 5.27 x 3.69 x 3.81 x 4.53 x 3.03 x 3.86 x 3.19 x 2.58 x
Nbr of stocks (in thousands) 16,00,000 16,00,000 15,82,082 14,44,464 14,45,434 14,45,434 - -
Reference price 2 6.030 4.760 4.920 5.320 4.720 7.400 7.400 7.400
Announcement Date 12/03/20 21/03/21 20/03/22 20/03/23 17/03/24 - - -
1EGP in Million2EGP
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 1,798 1,990 2,549 2,614 3,595 5,033 5,560 6,345
EBITDA 1 346.1 539.6 763.2 709.3 830 1,160 1,442 1,724
EBIT 1 281.1 349.5 509.5 444.1 650.8 959.4 1,151 1,428
Operating Margin 15.63% 17.57% 19.99% 16.99% 18.1% 19.06% 20.69% 22.51%
Earnings before Tax (EBT) 1 367.5 396.2 534.6 449.7 609.1 813 890 -
Net income 1 257.4 286.9 387.2 325.8 418.2 524 639 787
Net margin 14.32% 14.42% 15.19% 12.46% 11.63% 10.41% 11.49% 12.4%
EPS 2 0.1400 0.1500 0.2420 0.2036 0.2200 0.4285 0.4497 0.6282
Free Cash Flow 1 73.17 -235.9 366 - - -159 81.7 523
FCF margin 4.07% -11.86% 14.36% - - -3.16% 1.47% 8.24%
FCF Conversion (EBITDA) 21.14% - 47.96% - - - 5.67% 30.33%
FCF Conversion (Net income) 28.42% - 94.52% - - - 12.79% 66.45%
Dividend per Share - - - - - - - -
Announcement Date 12/03/20 21/03/21 20/03/22 20/03/23 17/03/24 - - -
1EGP in Million2EGP
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2023 Q3 2023 Q4 2024 Q1
Net sales 1 - 1,063 1,181
EBITDA 1 - 242.3 326.3
EBIT - - -
Operating Margin - - -
Earnings before Tax (EBT) - - -
Net income 1 119.7 107.2 182.2
Net margin - 10.08% 15.43%
EPS 0.0900 - -
Dividend per Share - - -
Announcement Date 26/11/23 17/03/24 26/05/24
1EGP in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - 181 516 1,717 1,595 504
Net Cash position 1 783 540 574 - - - - -
Leverage (Debt/EBITDA) - - - 0.255 x 0.6211 x 1.481 x 1.106 x 0.2924 x
Free Cash Flow 1 73.2 -236 366 - - -159 81.7 523
ROE (net income / shareholders' equity) 15% 14.7% 17.4% 15.3% 20.3% 24.7% 19.1% 21.1%
ROA (Net income/ Total Assets) 10.4% 10.5% 12.5% 9.7% 10.8% 10% 9.34% -
Assets 1 2,483 2,725 3,108 3,358 3,876 5,240 6,842 -
Book Value Per Share 2 1.140 1.290 1.290 1.170 1.560 1.920 2.320 2.870
Cash Flow per Share 2 0.2600 0.0900 0.4100 0.2000 0.3900 0.4000 0.7300 1.110
Capex 1 349 408 282 332 825 1,685 910 402
Capex / Sales 19.43% 20.5% 11.07% 12.69% 22.95% 33.48% 16.36% 6.33%
Announcement Date 12/03/20 21/03/21 20/03/22 20/03/23 17/03/24 - - -
1EGP in Million2EGP
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
7.4 EGP
Average target price
7.607 EGP
Spread / Average Target
+2.79%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. CLHO Stock
  4. Financials Cleopatra Hospitals Group S.A.E.